SIRT1 and urinary bladder cancer: Moreover, Cao et al.7 reported that HJURP-silencing could activate PPARγ and inhibit the p-SIRT1/t-SIRT1 signaling pathways in bladder cancer cells, which can lead to an increase in ROS and cause apoptosis.